Prevalence of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency among Malaria Patients in Southern Thailand: 8 Years Retrospective Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Erythrocytes deficient in glucose-6-phosphate dehydrogenase (G6PD) is more susceptible to oxidative damage from free radical derived compounds. The hemolysis triggered by oxidative agents such as primaquine (PQ) is used for the radical treatment of hypnozoites of P. vivax. Testing of G6PD screening before malaria treatment is not a common practice in Thailand, which poses patients at risk of hemolysis. This retrospective study aimed to investigate the prevalence of G6PD in malaria patients who live in Southern Thailand. Eight hundred eighty-one malaria patients were collected for 8-year from 2012 to 2019, including 785 (89.1%) of P. vivax, 61 (6.9%) of P. falciparum, 27 (3.1%) of P. knowlesi, and 8 (0.9%) of mixed infections. The DiaPlexC genotyping kit (Asian type) and PCR-RFLP were employed to determine the G6PD variants. The result showed that 5 different types of G6PD variants were identified in 26 cases (2.9%); 12/26 (46.2%) had Mahidol (487G>A) and 11/26 (42.3%) had Viangchan (871G>A) variants, while the rest had Kaiping (1388G>A), Union (1360C>T), and Mediterranean (563C>T) variants. G6PD Songklanagarind (196T>A) variant was not found in the study. Our result did not show a significant difference in the malaria parasite densities in patients between G6PD-deficient and G6PD-normal groups. According to our findings, testing G6PD deficiency and monitoring the potential PQ toxicity in patients who receive PQ are highly recommended.
Abstract
Erythrocytes deficient in glucose-6-phosphate dehydrogenase (G6PD) is more susceptible to oxidative damage from free radical derived compounds. The hemolysis triggered by oxidative agents such as primaquine (PQ) is used for the radical treatment of hypnozoites of P. vivax. Testing of G6PD screening before malaria treatment is not a common practice in Thailand, which poses patients at risk of hemolysis. This retrospective study aimed to investigate the prevalence of G6PD in malaria patients who live in Southern Thailand. Eight hundred eighty-one malaria patients were collected for 8-year from 2012 to 2019, including 785 (89.1%) of P. vivax, 61 (6.9%) of P. falciparum, 27 (3.1%) of P. knowlesi, and 8 (0.9%) of mixed infections. The DiaPlexC genotyping kit (Asian type) and PCR-RFLP were employed to determine the G6PD variants. The result showed that 5 different types of G6PD variants were identified in 26 cases (2.9%); 12/26 (46.2%) had Mahidol (487G>A) and 11/26 (42.3%) had Viangchan (871G>A) variants, while the rest had Kaiping (1388G>A), Union (1360C>T), and Mediterranean (563C>T) variants. G6PD Songklanagarind (196T>A) variant was not found in the study. Our result did not show a significant difference in the malaria parasite densities in patients between G6PD-deficient and G6PD-normal groups. According to our findings, testing G6PD deficiency and monitoring the potential PQ toxicity in patients who receive PQ are highly recommended.
참고문헌 (53)
- Lucio Luzzatto, "Glucose-6-Phosphate Dehydrogenase Deficiency", Hematology, 2016, pp.30(2), 373~393[DOI]
- Saúl Gómez-Manzo, "Functional and Biochemical Analysis of Glucose-6-Phosphate Dehydrogenase (G6PD) Variants: Elucidating the Molecular Basis of G6PD Deficiency", Catalysts, 7(5), pp.135~ (2017), MDPI AG[DOI]
- MD Cappellini, "Glucose-6-phosphate dehydrogenase deficiency", The Lancet, 371(9606), pp.64~74 (2008), Elsevier BV[DOI]
- Frank JE, "Diagnosis and management of G6PD deficiency", Am Fam Physician, 72, pp.1277~1282 (2005)
- Rosalind E Howes, "Spatial distribution of G6PD deficiency variants across malaria-endemic regions", Malaria Journal, 12(1), pp.418~ (2013), Springer Science and Business Media LLC[DOI]
- Rosalind E. Howes, "G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map", PLoS Medicine, 9(11), pp.e1001339~ (2012), Public Library of Science (PLoS)[DOI]
- Kanjaksha Ghosh, "Effect of inherited red cell defects on growth of Plasmodium falciparum: An in vitro study", Indian Journal of Medical Research, 147(1), pp.102~ (2018), Medknow[DOI]
- Marina Cappadoro, "Early Phagocytosis of Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Erythrocytes Parasitized by Plasmodium falciparum May Explain Malaria Protection in G6PD Deficiency", Blood, 92(7), pp.2527~2534 (1998), American Society of Hematology[DOI]
- Aldiouma Guindo, "X-Linked G6PD Deficiency Protects Hemizygous Males but Not Heterozygous Females against Severe Malaria", PLoS Medicine, 4(3), pp.e66~ (2007), Public Library of Science (PLoS)[DOI]
- Sophie Uyoga, "Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study", The Lancet Haematology, 2(10), pp.e437~e444 (2015), Elsevier BV[DOI]
- Judith Recht, "Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries", PLOS Neglected Tropical Diseases, 12(4), pp.e0006230~ (2018), Public Library of Science (PLoS)[DOI]
- "Testing for G6PD deficiency for safe use of primaquine in radical cure of P. vivax and P. ovale: Policy brief" (2016)[URL]
- "President’s Malaria Initiative: Thailand, Lao PDR and Regional Abbreviated Malaria Operation Plan FY 2019" (2019)[URL]
- Ric N Price, "Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis", The Lancet Infectious Diseases, 14(10), pp.982~991 (2014), Elsevier BV[DOI]
- Ella T. Nkhoma, "The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis", Blood Cells, Molecules, and Diseases, 42(3), pp.267~278 (2009), Elsevier BV[DOI]
- Usa Boonyuen, "Glucose-6-phosphate dehydrogenase mutations in malaria endemic area of Thailand by multiplexed high‐resolution melting curve analysis", Malaria Journal, 20(1), pp.194~ (2021), Springer Science and Business Media LLC[DOI]
- Charoenkwan P, "Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency in northern Thailand", Southeast Asian J Trop Med Public Health, 45, pp.187~193 (2014)
- Jitueakul S, "Characterization of G6PD genotypes in G6PD deficiency patients from Suratthani Hospital, Thailand", JAMS, 51, pp.66~71 (2018)
- Aya Ninokata, "Coexistence of five G6PD variants indicates ethnic complexity of Phuket islanders, Southern Thailand", Journal of Human Genetics, 51(5), pp.424~428 (2006), Springer Science and Business Media LLC[DOI]
- Vichai Laosombat, "Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) variants in the south of Thailand and identification of a novel variant (G6PD Songklanagarind)", Blood Cells, Molecules, and Diseases, 34(2), pp.191~196 (2005), Elsevier BV[DOI]
- Germana Bancone, "Characterization of G6PD Genotypes and Phenotypes on the Northwestern Thailand-Myanmar Border", PLoS ONE, 9(12), pp.e116063~ (2014), Public Library of Science (PLoS)[DOI]
- Kanchanavithayakul A, "Prevalence of glucose 6-phosphate dehydrogenase deficiency and genetic mutations among karen and lao populations in thailand", Southeast Asian J Trop Med Public Health, 48, pp.1308~1317 (2017)
- Suwapat Sathupak, "Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Lue ethnic group of northern Thailand", Scientific Reports, 11(1), pp.2956~ (2021), Springer Science and Business Media LLC[DOI]
- Papichaya Phompradit, "Prevalence and distribution of glucose-6-phosphate dehydrogenase (G6PD) variants in Thai and Burmese populations in malaria endemic areas of Thailand", Malaria Journal, 10(1), pp.368~ (2011), Springer Science and Business Media LLC[DOI]
- Bonito B, "Prevalence of glucose-6-phosphate dehydrogenase deficiency among vivax malaria patients at the Hospital for Tropical Diseases, Thailand", Southeast Asian J Trop Med Public Health, 50, pp.211~216 (2019)
- Thunchanok Khammanee, "A LAMP-SNP Assay Detecting C580Y Mutation in Pfkelch13 Gene from Clinically Dried Blood Spot Samples", Parasites, Hosts and Diseases, 59(1), pp.15~22 (2021), 대한기생충학ㆍ열대의학회
- Thunchanok Khammanee, "Molecular Surveillance of Pfelch13 and Pfmdr1 Mutations in Plasmodium falciparum Isolates from Southern Thailand", Parasites, Hosts and Diseases, 57(4), pp.369~377 (2019), 대한기생충학ㆍ열대의학회[DOI]
- Supinya Thanapongpichat, "Genetic Diversity of Plasmodium vivax in Clinical Isolates from Southern Thailand using PvMSP1, PvMSP3 (PvMSP3α, PvMSP3β) Genes and Eight Microsatellite Markers", Parasites, Hosts and Diseases, 57(5), pp.469~479 (2019), 대한기생충학ㆍ열대의학회[DOI]
- Schoone GJ, "Detection and quantification of Plasmodium falciparum in blood samples using quantitative nucleic acid sequence-based amplification", J Clin Microbiol, 38, pp.4072~5407 (2000)[DOI]
- Georges Snounou, "Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections", Molecular and Biochemical Parasitology, 58(2), pp.283~292 (1993), Elsevier BV[DOI]
- Moritoshi Iwagami, "First case of human infection with Plasmodium knowlesi in Laos", PLOS Neglected Tropical Diseases, 12(3), pp.e0006244~ (2018), Public Library of Science (PLoS)[DOI]
- O. Ainoon, "Glucose-6-phosphate dehydrogenase (G6PD) variants in Malaysian Malays", Human Mutation, 21(1), pp.101~101 (2002), Hindawi Limited[DOI]
- Narazah Mohd Yusoff, "Molecular Heterogeneity of Glucose-6-Phosphate Dehydrogenase Deficiency in Malays in Malaysia", International Journal of Hematology, 76(2), pp.149~152 (2002), Springer Science and Business Media LLC[DOI]
- "Updating the WHO G6PD classification of variants and the International Classification of Diseases, 11th Revision (ICD-11). Malaria Policy Committee Meeting. Background document for Session 7. 2019 October 2-4; Geneva, Switzerland" (2019)[URL]
- Jinyoung Lee, "Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among malaria patients in Upper Myanmar", BMC Infectious Diseases, 18(1), pp.131~ (2018), Springer Science and Business Media LLC[DOI]
- "Guide to G6PD Deficiency Rapid Diagnostic Testing to Support P. vivax Radical Cure" (2018)[URL]
- Yuxiang Huang, "Purification and detailed study of two clinically different human glucose 6-phosphate dehydrogenase variants, G6PDPlymouth and G6PDMahidol: Evidence for defective protein folding as the basis of disease", Molecular Genetics and Metabolism, 93(1), pp.44~53 (2008), Elsevier BV[DOI]
- Saúl Gómez-Manzo, "The Stability of G6PD Is Affected by Mutations with Different Clinical Phenotypes", International Journal of Molecular Sciences, 15(11), pp.21179~21201 (2014), MDPI AG[DOI]
- Shannon WN Au, "Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP + molecule and provides insights into enzyme deficiency", Structure, 8(3), pp.293~303 (2000), Elsevier BV[DOI]
- Kaplan JC, "Defective molecular variants of glucose-6-phosphate dehydrogenase and methaemoglobin reductase", J Clin Pathol Suppl(R Coll Pathol), 8, pp.134~141 (1974)
- Sergio Piomelli, "In vivo lability of glucose-6-phosphate dehydrogenase in GdA- and Gdmediterranean deficiency", Journal of Clinical Investigation, 47(4), pp.940~948 (1968), American Society for Clinical Investigation[DOI]
- Germana Bancone, "G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs", Frontiers in Pharmacology, 12, pp.638885~ (2021), Frontiers Media SA[DOI]
- Nimol Khim, "G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients", Malaria Journal, 12(1), pp.171~ (2013), Springer Science and Business Media LLC[DOI]
- Weiying Jiang, "Structure and function of glucose-6-phosphate dehydrogenase-deficient variants in Chinese population", Human Genetics, 119(5), pp.463~478 (2006), Springer Science and Business Media LLC[DOI]
- Wang J, "Nine different glucose-6-phosphate dehydrogenase(G6PD)variants in a Malaysian population with Malay, Chinese, Indian and Orang Asli(aboriginal Malaysian)backgrounds", Acta Med Okayama, 62, pp.327~332 (2008)[DOI]
- Eugenia Lo, "Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia", Malaria Journal, 18(1), pp.340~ (2019), Springer Science and Business Media LLC[DOI]
- Suttiphan Kitcharoen, "Relationship among glucose-6-phosphate dehydrogenase (G-6-PD) activity, G-6-PD variants and reticulocytosis in neonates of northeast Thailand", Clinica Chimica Acta, 442, pp.125~129 (2015), Elsevier BV[DOI]
- Carolina López, "Mechanisms of genetically-based resistance to malaria", Gene, 467(1-2), pp.1~12 (2010), Elsevier BV[DOI]
- Kodjo Ayi, "Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait", Blood, 104(10), pp.3364~3371 (2004), American Society of Hematology[DOI]
- Chanya Udom, "Trophic Behavior and Species Diversity of the <i>Anopheles barbirostris<", i> Complex (Diptera: Culicidae) in Thailand, 2021, pp.58(6), 2376~2384[DOI]
- Cindy S. Chu, "The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis", Wellcome Open Research, 4, pp.25~ (2019), F1000 Research Ltd[DOI]
- Ronnatrai Rueangweerayut, "Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers", The American Journal of Tropical Medicine and Hygiene, 97(3), pp.702~711 (2017), American Society of Tropical Medicine and Hygiene[DOI]
- Cindy S. Chu, "Primaquine-induced haemolysis in females heterozygous for G6PD deficiency", Malaria Journal, 17(1), pp.101~ (2018), Springer Science and Business Media LLC[DOI]
